Congress Report Hyperkalemia and RAAS-Inhibitors: New Therapeutic Option

被引：0
|
作者：
Fisch, S.
机构：
来源：
JOURNAL FUR KARDIOLOGIE | 2018年 / 25卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：44 / 46
页数：2
相关论文
共 50 条
  • [1] Fetotoxicity of RAAS-inhibitors
    Schink, Tania
    Onken, Marlies
    Wentzell, Nadine
    Dathe, Katarina
    Haug, Ulrike
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 522 - 523
  • [2] Long-term outcomes of children exposed to RAAS-inhibitors during pregnancy
    Schink, Tania
    Braitmaier, Malte
    Haug, Ulrike
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 527 - 528
  • [3] Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
    Weir, Matthew R.
    Bakris, George L.
    Bushinsky, David A.
    Mayo, Martha R.
    Garza, Dahlia
    Stasiv, Yuri
    Wittes, Janet
    Christ-Schmidt, Heidi
    Berman, Lance
    Pitt, Bertram
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (03): : 211 - 221
  • [4] mTOR inhibitors as a new therapeutic option for epilepsy
    Curatolo, Paolo
    Moavero, Romina
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (06) : 627 - 638
  • [5] Effects of short-term addition of NSAID to diuretics and/or RAAS-inhibitors on blood pressure and renal function
    Peder Nygård
    Frank G. A. Jansman
    Willemien J. Kruik-Kollöffel
    Alex F. W. Barnaart
    Jacobus R. B. J. Brouwers
    [J]. International Journal of Clinical Pharmacy, 2012, 34 : 468 - 474
  • [6] Effects of short-term addition of NSAID to diuretics and/or RAAS-inhibitors on blood pressure and renal function
    Nygard, Peder
    Jansman, Frank G. A.
    Kruik-Kolloffel, Willemien J.
    Barnaart, Alex F. W.
    Brouwers, Jacobus R. B. J.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (03) : 468 - 474
  • [7] Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality
    Beusekamp, Joost C.
    Tromp, Jasper
    Cleland, John G. F.
    Givertz, Michael M.
    Metra, Marco
    O'Connor, Christopher M.
    Teerlink, John R.
    Ponikowski, Piotr
    Ouwerkerk, Wouter
    van Veldhuisen, Dirk J.
    Voors, Adriaan A.
    van der Meer, Peter
    [J]. JACC-HEART FAILURE, 2019, 7 (11) : 970 - 979
  • [8] Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity
    Hernandez-Florez, Diana
    Valor, Lara
    [J]. REUMATOLOGIA CLINICA, 2016, 12 (06): : 303 - 306
  • [9] Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors
    Weir, Matthew R.
    Bushinsky, David A.
    Benton, Wade W.
    Woods, Steven D.
    Mayo, Martha R.
    Arthur, Susan P.
    Pitt, Bertram
    Bakris, George L.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2018, 131 (05): : 555 - +
  • [10] Phosphodiesterase-5 inhibitors in Eisenmenger syndrome: A new therapeutic option
    Mukhopadhyay, S
    Sharma, M
    Yusuf, J
    Ramakrishnan, S
    Gupta, MD
    Trehan, V
    Tyagi, S
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 155H - 155H
12345